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TITLE 
General public’s views on pharmacy public health services: Current situation and 
opportunities in the future 
 
ABSTRACT  
Objectives: To explore the experience of and willingness to use seven pharmacy public 
health services related to cardiovascular risk among the general public in England. 
Study design: Mixed-method study 
Methods: A mixed methods study, involving a cross-sectional survey using multiple 
distribution methods followed by a focus group discussion (FGD) with a sample of survey 
respondents.  
Results: From 3,596 approachable individuals, 908 questionnaires were completed, (response 
rate 25.3%). Few respondents (2.1-12.7%) had experienced any of the seven pharmacy public 
health services. About 40% stated they would be willing to use health check services, fewer 
(9.3-26.3%) were willing to use advisory services. More females, frequent pharmacy users 
and those in good health were willing to use services in general (P<0.05). Smokers, 
overweight individuals and those with alcohol-related problems were most willing to use 
specific advisory services supporting their problems (P<0.05). FGD identified barriers to 
service use; for example, frequent staff changes, seeing pharmacist as medicines suppliers 
and concerns about competence for these services. 
Conclusion: The general public are receptive to pharmacy public health services. 
Pharmacists must consider barriers if uptake of services is to increase. 
Keywords: general public, pharmacy public health services, mixed-methods, cardiovascular 
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INTRODUCTION 
In the last few decades, community pharmacists have begun to contribute significantly to 
public health in many countries.1 Potential pharmacy public health services encompass 
interventions for health education, screening for and supporting non-communicable disease 
management such as weight management, smoking cessation service, screening blood 
pressure and blood sugar, etc.2 
 Cardiovascular disease (CVD) is one of the world leading causes of mortality. The 
total deaths of ischemic heart and cerebrovascular diseases are predicted to be 13.4% and 
10.6% in 2030.3 Published evidence has demonstrated that community pharmacy has 
potential to contribute to preventing CVD particularly through screening for CVD risk 
factors, but also by providing a range of activities such as support with lifestyle change and 
medication use.4, 5 Studies in Australia, Thailand, England and elsewhere have shown that 
pharmacies can deliver such services thereby increasing access to CVD screening services. 5-7  
 All community pharmacies in England must contribute to public health by providing 
public health campaigns,8 principally through display and distribution of health leaflets.9  In 
addition, local health organisations can choose to commission further public health services 
through community pharmacies depending on local needs.9 Such services include for 
example stopping smoking assistance, screening for high alcohol intake and NHS health 
checks.10-12 
 The ‘general public’ includes both those with diagnosed medical conditions and 
those who perceive themselves to be healthy. Among this latter group, many may have 
undiagnosed problems, which increase their risk of CVD.13 Prevention of CVD is a high 
priority in England and pharmacy-based services which can contribute to this agenda are 
becoming increasingly widespread. Because most people use a pharmacy at some time,14 
3"
"
pharmacies can provide opportunistic screening to help identify these issues and thus support 
public health programmes.  
 The general public includes both users of pharmacies and pharmacy services and 
non-users, any of whom may benefit from such services. Published evidence is however 
limited on how the general public actually views pharmacy public health service provision, 
since previous studies have mostly explored the views of users of pharmacies and pharmacy 
services. A systematic review found that pharmacy consumers had a generally positive view 
of the community pharmacist as a public health service provider, however, most were rarely 
offered unsolicited public health services.15 Surveys which have explored the views of the 
wider public have mostly focused on individual services, including CVD screening 
services,16, 17 weight management18 and alcohol screening.19 A national survey of public 
views in Australia found low awareness of pharmacy CVD screening services.16 One small 
survey in Liverpool, England, which included the general public perceiving themselves as 
healthy, found they had little awareness of pharmacist’s involvement in public health in 
general.20 This is also true of findings from surveys which focus on specific services, 16, 18 
and is reflected in low use of pharmacy public health services.15, 18 Despite this, surveys do 
indicate potential acceptance of pharmacy public health services,  among both pharmacy 
users10 and the general public,19, 20 but no work to date has explored what factors influence 
this. 
 This study, therefore, aimed to explore in a wide, cross-sectional survey, the 
experience of and willingness to use pharmacy public health services among the general 
public in England. 
 
METHODS 
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Study design 
 The study was mixed methods and involved a cross-sectional survey followed by a 
focus group discussion (FGD), conducted in Sefton, a diverse area of England, which is 
ranked overall 83rd most deprived of the 354 English authority areas, but also includes 
locations with the lowest deprivation ranking.21 At the time of the study, all pharmacies in 
this area were commissioned to provide smoking cessation services, selected pharmacies 
were commissioned to provide NHS Health Checks17 and some also provided weight 
management services.22 
Ethical issues 
Ethical approval was received from Liverpool John Moores University. (Ref: 09/PBS/005) 
Consent was obtained from all participants. Survey data were anonymous.  
Survey 
 Data collection 
 The survey used multiple distribution modes to maximize representativeness of the 
general population.23, 24 Questionnaires were administered by seven distribution methods. 
Two approaches were used; interviewer-assisted (street, door-to-door and telephone survey) 
and self-completion (single- and double-mailing, postal survey to public/private organizations 
and questionnaires dropped-off at public/private organizations). The variation in response 
rates and demographic details arising from different distribution methods are reported 
elsewhere.25 The survey aimed to obtain 1,200 responses from the general public aged 18 
years or over. Screening questions were used to exclude people under 18 and also health 
professionals, since their work experience in health had the potential to influence their views.  
Instrument 
 Services of interest 
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 CVD is recognized as a major health priority in the study location, particularly in 
areas of high deprivation.26 This survey included seven services of relevance to CVD 
prevention which could be provided by pharmacies, derived from the published literature.5, 20 
These were four services for health advice (smoking cessation, sensible drinking, losing 
weight, heart health) and three health checks (blood pressure, blood sugar and cholesterol 
monitoring). 
 Demographic and health variables 
 The questionnaire incorporated fourteen demographic and health-related variables to 
characterize respondents. Demographic characteristics were: gender, age groups, ethnicity, 
education status, work status, socioeconomic status and deprivation level. Socioeconomic 
status (SES) was condensed into three categories based on respondents’ occupation; lower 
(un-skilled/manual occupations); middle (skilled manual/administrative occupations); and 
higher (managerial/professional occupations).27 Deprivation level was grouped into five 
quintiles (1 is the highest and 5 is the lowest), based on where respondents live.21 Health-
related lifestyle variables were: smoking, alcohol use, fruit/vegetable consumption, exercise 
and general health. Seven chronic health conditions, related to the proposed pharmacy 
services, were also included: hypertension, diabetes, high cholesterol, obesity, heart disease, 
smoking- and alcohol-related problems. In addition, respondents were also characterized 
depending on the use of regular medication and of pharmacies. Pharmacy user type was 
defined by the frequency of pharmacy visits in the last 6 months. A frequent user was defined 
as an individual who had visited a pharmacy more than once a month while an infrequent 
user visited less than once a month or never used a pharmacy. 
 Questionnaire validation
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 The questionnaire was designed and iteratively reviewed by the research team before 
face validity testing to evaluate content and understanding by ten volunteers. Further piloting 
was conducted to test content validity and questionnaire reliability by both interviewer-
assisted and self-completion, among 100 members of the general public in Liverpool. Content 
validity was intensively examined through cognitive interview techniques,28 to ensure the 
suitability of the questionnaire. It was slightly revised prior to the fieldwork.  
 Outcome measures 
 Key outcome measures were experience of, and willingness to use, the seven 
pharmacy public health services. Respondents’ experiences of each service was measured 
using bivariate (yes/no) options. Willingness to use the seven services in the future was 
measured categorically (yes, maybe, or no), then responses were dichotomized to positive 
(answered ‘yes or maybe’) or negative view (answered ‘no’).  
 Data analysis 
 Descriptive analysis was performed to illustrate the overall results of demographic 
characteristics, health variables and key outcomes. Binary logistic regression was used to 
determine associations between demographic and health variables and versus experience and 
willingness to use services to identify opportunity for pharmacy public health services. An 
odds ratio (OR) and its 95% confidence interval (95% CI) were used to interpret the 
significance of an association, using a P-value of less than 0.05 as the cut-off point for 
significance.  
Focus group discussion 
Recruitment of participants 
  An invitation explaining the objectives of the FGD was enclosed with postal survey 
packs. Survey respondents who were interested in taking part returned a completed 
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participation form with their completed questionnaire to the research team. FGD invitations 
were additionally offered to interested participants when conducting surveys on the street and 
via telephone. Potential participants were selected from those agreeing to participate, based 
on SES to ensure group diversity. Postal and telephone contact was made to schedule the 
FGD once the survey findings had been analysed and summarized. All FGD participants were 
offered a £25 shopping voucher for their time and £5 cash for travel costs. 
Conduct of the focus group  
  Participants who agreed to attend the FGD were provided with a summary report of 
the survey findings a few days prior to the FGD. The report used simple descriptive results 
and bar charts to help participants understand the findings. The FGD was held in a neutral 
location and lasted approximately one hour. Written consent was obtained prior to audio 
recording the discussion. KS facilitated the FGD while a second person took field notes. 
Focus group topic guide 
 A topic guide was derived from the descriptive survey findings and was also 
included in the summary report, to enable participants to consider these issues prior to the 
FGD. Key points for discussion were; 
 Use of pharmacy public health services 
• Why don’t people use new pharmacy services? 
 Willingness to use pharmacy public health services in the future 
• What makes people unlikely to use services related to health advice? 
• Why are they more willing to use health check services? 
• Why would elderly people be less willing to use pharmacy services when 
compare to younger groups? 
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• What may make people from more deprived areas more willing to use pharmacy 
services compared to those living in affluent areas? 
 Data analysis  
 The discussion was transcribed verbatim and analysed thematically. NVivo version 
9 was used to assist with managing the text data. A number of codes around potential themes 
were created inductively and reviewed to ensure appropriateness before creating themes. 
 
RESULTS 
Survey results 
 Demographic characteristics 
 A total of 4,988 general public were approached using seven different survey modes. 
Of these, 3,596 individuals were willing to consider taking part in the survey, 908 
questionnaires were completed, yielding an overall response rate of 25.3% 
 This survey obtained views mostly from females (60.4%) and those aged between 
35-64 (54.0%), which are similar to the population distribution of both the study area and 
England as a whole. (Table1) Almost all were white, which corresponded to the local 
population but is lower than national data. Respondents were less representative of both local 
and national populations in terms of education, with proportionately fewer respondents 
having only school-level education. Fewer than half (42.5%) were working, slightly lower 
than reported proportion in employment both locally and nationally. Based on their 
occupations, most respondents were classed as of high socioeconomic status (62.5%). 
However, based on postcode, the proportion of respondents within each of the five quintiles 
of deprivation was well matched to the Sefton profile (Table 1). The proportion of smokers 
(18.2%) and the distribution of general health status in the survey respondents were similar to 
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both local and national data, but the proportion of respondents who were increasing risk 
drinkers (39.0%), had a healthy diet (32.3%), were physically active (53.0%) and  overweight 
(54.2%), was higher than local and national figures. 
 Most respondents (96.2%) were users of pharmacies, but about a third (35.8%) were 
infrequent users, including the 3.8% who never used a pharmacy. Respondents aged 35-64 
years (49.6%) and school educated (49.5%) were likely to use pharmacy more frequently 
(Chi-square, P < 0.001), while there were no differences apparent between genders. The top 
three chronic diseases respondents reported they were diagnosed with were hypertension 
(31.5%), obesity (28.4%) and high cholesterol (25.1%). Respondents with at least one self-
reported diagnosis were more likely to also self-report poor health (Chi-square, P < 0.001). 
 Experience of, and willingness to use, pharmacy public health services 
 Overall, few respondents (Figure 1) had experienced any of the individual pharmacy 
public health services, with the most frequent experience being having a blood pressure check 
(12.7%). However, approximately 40% stated they would be willing to use any of the health 
checks, while about 25% would maybe use them. Fewer respondents were willing to use a 
pharmacy for any of the advisory services, with healthy heart advice being most frequently 
selected of these four services. Overall, fewer than 20% of respondents stated they would use 
a pharmacy for specific lifestyle advice on smoking cessation, sensible drinking or losing 
weight (Figure 1).  
 Factors affecting willingness to use pharmacy public health services 
 Three factors had a major influence on willingness to use pharmacy public health 
services: greater willingness was found among females, frequent pharmacy users and 
respondents with self-rated fair or good health. Females were more likely to be willing to use 
four of the seven services (weight management services and all three health checks), frequent 
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pharmacy users were more willing to use smoking cessation services, advice on safe 
drinking, weight management, BP check and blood sugar check, while respondents who rated 
their health as poor were less willing to use all services except smoking cessation support 
compared to those rating their health as fair or good. Older people were in general slightly 
less willing to use all services, but this only reached statistical significance for smoking 
cessation services. There were trends towards reduced willingness to use services among 
those of higher SES, except smoking cessation which was favoured by those in the middle 
SES group. Education level and deprivation status did not appear to influence willingness to 
use services. 
 Specific behaviours and medical conditions also influenced willingness to use 
relevant services. Smokers were over sixteen times more likely to use a pharmacy for advice 
for stopping smoking than non-smokers (OR=15.96, 95%CI 8.70-29.27) and respondents 
with smoking-related problem were almost 5-times more likely to do so (OR=4.86, 95% CI 
2.30-10.25). Willingness to seek advice for sensible drinking was also higher among 
smokers, however alcohol drinkers were less likely to want to use smoking cessation services 
compared to low risk drinkers, despite smoking and drinking behaviours being seen as 
complementary.29 Persons with alcohol-related problems were almost three times more likely 
to express willingness to use a pharmacy for advice on drinking (OR=2.82 95%CI 1.02-7.75), 
while increasing risk drinkers were also more positive about this service than low risk 
drinkers. Weight management services were mostly favoured by those who were overweight 
or reporting obesity as a health problem, but also by those reporting diabetes. Hypertensive 
and diabetic persons were however less willing to use pharmacy for a blood pressure check, 
while diabetic respondents were less likely to use cholesterol checks. 
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Focus group results 
 Participants 
 Thirty survey respondents returned participation forms; two aged 18-40 years, 16 
aged 41-60 years and 11 over 60 years old. However only seven, all aged over 40, agreed to 
take part when contacted by telephone and of those, only five respondents eventually 
participated, three of whom were male. Four participants held managerial/professional 
occupations and one was classified as having an unskilled/manual occupation. 
 Focus group findings 
 Several potential barriers to the use of pharmacy public health services were raised 
by FGD members to explain the survey results. They believed that the public sometimes 
viewed community pharmacists as strangers because of frequent staffing changes or use of 
locums. This led to the consideration that this might reduce consumer confidence in 
pharmacists maintaining confidentiality of customers’ personal information and discourage 
good rapport with regular pharmacy users. 
 “…Well it’s not if you use the same pharmacy, but you wouldn’t trust them with 
personal information…” [P4]  
 “…Even if you use the same pharmacy, there’s not always the same pharmacist 
there...”[P2] 
 It was considered that the general public may be unsure of the competency of 
community pharmacists to provide health advice, as there was a perception that this needed 
well-trained professional staff. In contrast, participants suggested that providing formal health 
checks involving the use of instrumentation may contribute to customers having confidence 
in the results.  
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 “…if you look at the figures, both at the green [results for health checks] 39, 40, 
40% - everything starts with the blue [results for health advice] and that drops down where 
the word ‘advice’ comes in.  In other words, the other is just a test. And they don’t think that 
they [pharmacists]’re able to give them that advice…” [P4] 
 It was agreed that people, particularly the elderly, who are already diagnosed with 
any CVD related-disease would have been followed up on a regular basis by their GPs, thus 
would not feel it was necessary (or appropriate) to seek services from other settings.  
 “…a lot of elderly people are on some sort of medication from the GP so they 
automatically keep going back to the GP because they do have that trust in them and they 
don’t have the need to go to the pharmacy… [P1]  
 Participants also inferred that middle-aged people may perceive themselves as being 
invincible. Moreover, perhaps, people in employment may have health check-ups regularly, 
advocated either by the company they work for or through private health insurance. 
Therefore, these health services might not be of interest to them.  
 “…It’s just people think ‘I’m OK, I’m fit, I’m well’…” [P3] 
 “…also the middle aged group…they’re employed, those sort of things [health 
checks] are done through their work…because a lot of companies do look after those 
things…” [P1] 
 Participants commented that people in more affluent areas were perhaps well-
educated with higher income, and were thus able to live healthier lives. As a consequence, 
such people may have fewer health needs.   
 “…People in the more deprived areas are not as healthy as those in the more 
affluent areas…maybe they don’t get the better foods; they get a lot of processed foods for 
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convenience and generally just smoke more and have a bit more pressure so they might have 
high blood pressure…” [P1] 
 A lack of advertising of the availability of services was felt to be a factor 
contributing to low awareness among the general public. Additionally, they suggested that 
information regarding how pharmacy public health services related to other health care 
services was not clear.  
 “…I just have a question: if…you go to the pharmacy and they say, ‘You’ve got high 
blood pressure’. What do they [community pharmacists] do with that result?...” [P5] 
In addition, participants considered that people have become accustomed for most of 
their lifetime to viewing a community pharmacy only for medicine supply and a pharmacist 
as a medicine expert. They felt that it may be difficult to change these attitudes, particularly 
in the elderly.  
“…I’m brought up in a village outside and there’s a village doctor and there’s a 
village chemist. You know, my parent told me that…the chemist just did the 
prescriptions…And it’s hard to break a lifetime habit…” [P4] 
 
DISCUSSION 
 Almost all respondents in this study were pharmacy users, but their experience of 
individual pharmacy public health services was low, with only 10% or fewer of respondents 
having actually used any of these services. However there was an overall willingness to use 
these services with specific disease-related health checks being regarded more positively than 
services focusing on lifestyle. Frequent pharmacy users, females and those in better health 
were most likely to use any service, but specific services were viewed as acceptable by 
respondents with particular characteristics, behaviours and conditions. The FGD enabled 
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some of these factors to be explored further and highlighted key issues which could be 
barriers to the use of these services. 
 Other studies have investigated the general public’s views on using specific 
pharmacy services for CVD screeing,17 weight management18 and advice on alcohol 
consumption.20 Our results suggest that pharmacy public health services in general appear to 
be underutilized, which concurs with these findings.  Previous studies have suggested that in 
fact the public view pharmacy’s role in a range of public health services as limited.17, 19 The 
focus group findings have some resonance with the findings of other studies, in that previous 
work suggests concerns about privacy and confidentiality, competency15, 30 and the potential 
for both these and good rapport to be adversely affected by frequent use of locums.30 Other 
factors found to reduce willingness to use pharmacy services are lack of awareness of the 
availability of consultation rooms, lack of awareness of services and the busyness of 
pharmacies. 15, 19, 31 One further factor raised by FDG participants is that their lifetime view 
of the pharmacist as an expert on medicines31 needs to change in order to accept public health 
services.  
Strengths and limitations 
The survey questionnaire used in this study was comprehensively developed from the 
findings of qualitative work involving the general public and relevant published literature.13, 
20, 31 The findings represent the general public’s (societal) perspective, rather than the views 
only of service users or pharmacy customers, as is the case with many other studies10, 15, 31 
seeking views on pharmacy services.  Data were gathered using a range of different methods 
to maximize the diversity of the sample. Response rates for self-completion methods were 
fairly low (5.1-26.5%), but higher for interviewer-assisted approaches (28.5-34.5%), hence 
there is a possibility of non-responder bias, which is a common problem for health surveys.32 
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Moreover interviewer-assisted approaches could have led to social desirability bias. The 
survey respondents were reasonably representative of Sefton’s population in terms of 
demographic characteristics, including deprivation status, but not SES. However the 
proportion of respondents reporting increasing risk drinking, eating well, being physically 
active and overweight differed slightly from those reported in  public health data from both 
Sefton and England.26, 33 Generalization of the study findings and extrapolation to the wider 
population may be limited, due to the localized setting. The study questionnaire incorporated 
standard tools to measure relevant lifestyle behaviours, such as AUDIT-C,34 BMI 
calculation,35 standard recommendations for eating healthily,36 and exercise37 and also 
included self-reported conditions relevant to the services being investigated. This allowed 
indicators of the ‘need’ for public health services to be mapped against willingness to use 
these services. The use of a FGD involving survey respondents provided an important 
mechanism which helped to explain the findings from the perspective of respondents i.e. the 
general public, rather than that of researchers.38 However, we acknowledge there was 
insufficient participation from younger respondents and people from lower SES, who may 
have had different views.  
 
CONCLUSION 
Although these results confirm that the general public has been slow to utilize pharmacy 
public health services, they suggest that the public are receptive to a wide range of services 
which could be offered in relation to reducing CVD. Inevitably, respondents with specific 
health needs showed greater willingness to use services specific to those problems, but 
overall willingness to use services was lower among males, infrequent users of pharmacies 
and those with self-reported poor health. Pharmacists need to consider these factors and the 
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barriers to service use identified in this and other studies to promote their services to relevant 
populations and maximize uptake. 
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Table 1 Demographics characteristics and health of respondents 
Survey data Local and national statistics (%) 
 Count % Sefton England  
Gender (N=899)     Gendera 
   Male 356 39.6 47.0 49.1 Male 
   Female 543 60.4 53.0 50.9 Female 
Age (N=900)     Agea 
18- 34 y 105 11.2 18.3 21.9 16-29 
35 – 64 y 486 54.0 50.9 51.9 30-59 
≥65 y 313 34.5 30.8 26.2 ≥60 
Ethnicity (N= 895)     Ethnicitya 
   White 873 97.5 98.4 90.9 White 
   Non-white 22 2.5 1.6 9.1 Non-white 
Education (N=870)     Educationb 
   School (primary or secondary school) 381 43.8 59.5 58.4 GCSE* achieved 
   College/Further education 277 31.8    
   University (bachelor/postgraduate) 212 24.4    
Work status (N=899)     Economic activitya 
   Not working 126 14.0 10.5 5.7 Unemployed 
   Retired 391 43.5    
   Working (Full time/Part time) 382 42.5 55.7 60.6 Employed 
Socioeconomic status (N=856)   
n/a    Lower 187 21.8    Middle 134 15.7 
   Higher 535 62.5 
Deprivation (N=820)      
   1 (highest deprived) 188 22.9 23.7 19.8  
   2 171 20.9 17.7 19.9  
   3 148 18.0 23.4 20.1  
   4 160 19.5 21.1 20.1  
   5 (least deprived) 153 18.7 14.1 20.2  
Smoker (N=896) 163 18.2 19.3 21.2 Adult smokingb 
Alcohol drink (N=876)      
   Safe drinker 353 40.3    
   Unsafe drinker 342 39.0 21.8 23.6 Higher risk drinkerb 
Fruit/vegetable intake (N=878)      
≥ 5 a day 283 32.3 26.5 28.7 Healthy eatingb 
Exercise (N=895)      
≥ 3 times a week 474 53.0 10.9 11.5 Physically activeb 
Weight (N=768)      
   Normal 352 45.8    
   Overweight (BMI ≥ 25 kg/m2) 416 54.2 23.9 24.2 Obese adultsb 
General Health (N=891)     General healtha 
   Poor 67 7.5 11.2 9.2 Not good 
   Fair 217 24.4 21.7 22.2 Fairly good 
   Good 607 68.1 67.0 68.6 Good 
Taking medication regularly (N=892) 577 64.7    
Pharmacy user type (N=896)      
   Infrequent users 321 35.8    
   Frequent user  575 64.2    
Chronic health conditions      
Hypertension (N=887) 279 31.5    
Diabetes (N=884) 98 11.1    
High Cholesterol (N=879) 221 25.1    
Obesity (N=885) 254 28.4    
Heart Disease (N=886) 107 12.1    
Smoking related problem (N=884) 47 5.3    
Alcohol related problem (N=882) 23 2.6    
23"
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Source: *GCSE: General Certificate of Secondary Education  
aSefton Socioeconomic data (Sefton Council Planning and Economic Regeneration Department 2006) 
bSefton Health Profile 2011 (The Network of Public Health Observatories 2009)  
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Table 2 Associations between willingness to use pharmacy public health services and demographic and health variables 
 Odds Ratio, 95% Confidence Interval 
 Stopping smoking Sensible drinking Weight management 
Heart health 
advice 
Blood pressure 
check Cholesterol check Blood sugar check 
Gender (Reference = Male) 
Female 0.94 (0.55-1.63) 0.82 (0.51-1.31) 1.92* (1.29-2.85) 1.15 (0.80-1.66) 1.71* (1.17-2.50) 1.88* (1.28-2.75) 1.54* (1.06-2.24) 
Age group (Reference = age  ≤  34 y) 
35 – 64 y 0.40* (0.19-0.88) 0.55 (0.28-1.06) 0.78 (0.42-1.46) 0.76 (0.41-1.38) 0.72 (0.36-1.42) 0.80 (0.40-1.58) 0.74 (0.38-1.43) 
≥ 65 y 0.27* (0.09-0.84) 0.39 (0.15-1.03) 0.57 (0.25-1.29) 0.55 (0.25-1.22) 0.51 (0.22-1.22) 0.51 (0.21-1.21) 0.44 (0.19-1.01) 
Work status (Reference = Not working) 
Retired 0.60 (0.22-1.65) 0.74 (0.31-1.77) 0.55 (0.27-1.11) 0.86 (0.44-1.69) 0.66 (0.32-1.35) 0.79 (0.39-1.64) 0.69 (0.33-1.41) 
Working 1.64 (0.74-3.64) 1.20 (0.61-2.36) 0.76 (0.42-1.38) 1.34 (0.76-2.37) 0.91 (0.48-1.72) 1.03 (0.55-1.94) 0.76 (0.41-1.43) 
Socioeconomic status (Reference = Lower) 
Middle 2.56* (1.09-6.00) 0.98 (0.49-1.98) 1.07 (0.58-1.99) 0.89 (0.49-1.62) 1.09 (0.57-2.08) 0.91 (0.48-1.74) 0.81 (0.43-1.51) 
Higher 1.82 (0.85-3.94) 0.67 (0.36-1.24) 0.72 (0.42-1.22) 0.72 (0.43-1.18) 0.82 (0.48-1.40) 0.71 (0.41-1.21) 0.67 (0.39-1.13) 
Smoking (Reference = Non-smoker) 
Yes 15.96* (8.70-29.27) 1.96* (1.14-3.38) 0.93 (0.56-1.56) 1.34 (0.82-2.21) 0.92 (0.55-1.54) 0.83 (0.49-1.40) 0.86 (0.52-1.44) 
Alcohol drink (Reference = Non-drinker) 
Safe drinker 0.50* (0.26-0.95) 0.92 (0.48-1.74) 0.82 (0.50-1.34) 1.11 (0.70-1.76) 1.58 (0.98-2.55) 1.67* (1.03-2.70) 1.59 (0.99-2.56) 
Unsafe 
drinker 0.33* (0.16-0.68) 1.92* (1.01-3.66) 0.93 (0.54-1.59) 1.08 (0.65-1.78) 1.37 (0.82-2.32) 1.48 (0.88-2.50) 1.34 (0.80-2.23) 
Weight (Reference = Normal) 
Overweight 1.10 (0.66-1.86) 0.73 (0.47-1.15) 2.72* (1.85-4.00) 1.26 (0.88-1.79) 1.33 (0.91-1.93) 1.27 (0.87-1.85) 1.13 (0.79-1.64) 
General Health (Reference = Poor health) 
Fair 1.81 (0.62-5.34) 3.00 (0.93-9.62) 2.41* (1.10-5.31) 2.48* (1.20-5.12) 2.57* (1.26-5.26) 2.61* (1.27-5.38) 2.37* (1.16-4.86) 
Good 1.83 (0.64-5.26) 3.42* (1.09-10.72) 2.21* (1.03-4.74) 2.37* (1.18-4.78) 3.33* (1.67-6.65) 2.73* (1.37-5.45) 2.71* (1.36-5.39) 
Pharmacy user type (Reference = Infrequent user) 
Frequent 
user 1.77 (1.01-3.10) 2.19* (1.33-3.60) 1.73* (1.16-2.60) 1.64* (1.13-2.39) 1.57* (1.05-2.33) 1.47 (0.99-2.19) 1.63* (1.10-2.40) 
Note:*P-value < 0.05 
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Table 3 Associations between willingness to use pharmacy public health services and chronic health conditions 1#
Independent 
variables 
Stopping smoking Sensible drinking Weight management Heart health advice Blood pressure check Cholesterol check Blood sugar check 
N(%) OR (95%CI) N(%) 
OR 
(95%CI) N(%) 
OR 
(95%CI) N(%) 
OR 
(95%CI) N(%) 
OR 
(95%CI) N(%) 
OR 
(95%CI) N(%) 
OR 
(95%CI) 
Hypertension               
   No 134(23.1) 1.00 134(23.2) 1.00 217(37.5) 1.00 309(53.4) 1.00 403(68.7) 1.00 403(68.9) 1.00 386(66.1) 1.00 
   Yes 
59(22.6) 
1.03 
(0.69-1.55) 56(21.4) 
1.00 
(0.67-1.50) 108(41.1) 
1.00 
(0.71-1.41) 133(51.0) 
0.89 
(0.64-1.24) 166(60.8) 
0.69(0.49-
0.97) 165(60.9) 
0.74(0.52-
1.04) 155(57.4) 
0.71 
(0.52-1.03) 
Diabetes               
   No 179(23.9) 1.00 169(22.6) 1.00 276(36.8) 1.00 395(52.7) 1.00 513(67.2) 1.00 514(67.6) 1.00 489(64.4) 1.00 
   Yes 
12(13.5) 
0.42 
(0.21-0.85) 21(23.6) 
1.14 
(0.64-2.05) 48(52.7) 
1.78* 
(1.09-2.90) 46(51.1) 
0.89 
(0.55-1.43) 52(55.9) 
0.62(0.38-
1.00) 50(54.3) 
0.59(0.36-
0.95) 49(53.3) 
0.66 
(0.41-1.07) 
High 
cholesterol               
   No 146(23.2) 1.00 153(24.4) 1.00 241(38.4) 1.00 333(53.1) 1.00 422(66.2) 1.00 427(67.2) 1.00 410(64.7) 1.00 
   Yes 
46(22.1) 
1.08 
(0.69-1.69) 37(17.7) 
0.64 
(0.40-1.01) 83(39.7) 
0.86 
(0.59-1.26) 107(51.2) 
0.93 
(0.65-1.34) 142(65.7) 
1.30 
(0.89-1.91) 136(63.6) 
1.13 
(0.77-1.66) 127(59.3) 
1.02 
(0.70-1.48) 
Obesity               
   No 146(24.3) 1.00 138(23.0) 1.00 200(33.3) 1.00 315(52.2) 1.00 413(67.3) 1.00 409(66.8) 1.00 389(63.7) 1.00 
   Yes 
47(19.7) 
0.75 
(0.50-1.13) 52(21.8) 
0.96 
(0.65-1.42) 125(52.1) 
2.22* 
(1.60-3.06) 127(53.4) 
1.08 
(0.79-1.49) 155(63.3) 
0.93 
(0.67-1.29) 158(65.0) 
1.08 
(0.77-1.50) 152(62.6) 
1.11 
(0.80-1.54) 
Heart disease               
   No 171(23.1) 1.00 170(23.0) 1.00 291(39.4) 1.00 387(52.3) 1.00 503(66.5) 1.00 508(67.6) 1.00 485(64.6) 1.00 
   Yes 
21(21.2) 
0.82 
(0.46-1.43) 20(20.2) 
0.87 
(0.50-1.53) 34(33.7) 
0.66 
(0.41-1.06) 56(56.0) 
1.20 
(0.76-1.88) 65(63.7) 
0.98 
(0.61-1.55) 59(57.8) 
0.74 
(0.47-1.16) 56(54.9) 
0.75 
(0.48-1.18) 
Smoking related problems              
   No 169(21.3) 1.00 172(21.7) 1.00 309(38.9) 1.00 415(52.3) 1.00 539(66.5) 1.00 539(66.9) 1.00 513(63.7) 1.00 
   Yes 
24(55.8) 
4.86* 
(2.30-10.25) 18(40.9) 
1.93 
(0.90-4.12) 16(35.6) 
0.68 
(0.32-1.47) 25(56.8) 
1.35 
(0.67-2.72) 27(58.7) 
1.01 
(0.49-2.08) 26(56.5) 
1.02 
(0.49-2.09) 26(56.5) 
1.14 
(0.56-2.34) 
Alcohol related problems              
   No 180(22.1) 1.00 178(21.9) 1.00 316(38.7) 1.00 430(52.8) 1.00 554(66.6) 1.00 554(66.9) 1.00 528(63.8) 1.00 
   Yes 
13(56.5) 
2.05 
(0.75-5.61) 11(50.0) 
2.82* 
(1.02-7.75) 9(42.9) 
1.17 
(0.41-3.34) 9(45.0) 
0.59 
(0.22-1.61) 11(50.0) 
0.51 
(0.19-1.36) 10(45.5) 
0.42 
(0.15-1.13) 10(45.5) 
0.44 
(0.16-1.20) 
Note: Table represents number and proportion of respondents who would be willing to use (yes and maybe) pharmacy public health services within categories. Odds ratio (OR) 2#
of 1.00 indicates a reference category. *P-value < 0.05 3#
 4#
